» Articles » PMID: 25709439

High Molecular Weight Chitosan Derivative Polymeric Micelles Encapsulating Superparamagnetic Iron Oxide for Tumor-targeted Magnetic Resonance Imaging

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2015 Feb 25
PMID 25709439
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Magnetic resonance imaging (MRI) contrast agents based on chitosan derivatives have great potential for diagnosing diseases. However, stable tumor-targeted MRI contrast agents using micelles prepared from high molecular weight chitosan derivatives are seldom reported. In this study, we developed a novel tumor-targeted MRI vehicle via superparamagnetic iron oxide nanoparticles (SPIONs) encapsulated in self-aggregating polymeric folate-conjugated N-palmitoyl chitosan (FAPLCS) micelles. The tumor-targeting ability of FAPLCS/SPIONs was demonstrated in vitro and in vivo. The results of dynamic light scattering experiments showed that the micelles had a relatively narrow size distribution (136.60±3.90 nm) and excellent stability. FAPLCS/SPIONs showed low cytotoxicity and excellent biocompatibility in cellular toxicity tests. Both in vitro and in vivo studies demonstrated that FAPLCS/SPIONs bound specifically to folate receptor-positive HeLa cells, and that FAPLCS/SPIONs accumulated predominantly in established HeLa-derived tumors in mice. The signal intensities of T2-weighted images in established HeLa-derived tumors were reduced dramatically after intravenous micelle administration. Our study indicates that FAPLCS/SPION micelles can potentially serve as safe and effective MRI contrast agents for detecting tumors that overexpress folate receptors.

Citing Articles

Chitosan-PVA-PVP/nano-clay composite: a promising tool for controlled drug delivery.

Ali M, Mir S, Atanase L, Abid O, Kazi M RSC Adv. 2024; 14(22):15777-15790.

PMID: 38752154 PMC: 11094589. DOI: 10.1039/d4ra02959c.


Nanoclay Reinforced Ternary Blends Based on Biodegradable Polymers for Drug Delivery Application.

Ali M, Mir S, Abid O, Yawer M, Ullah I Int J Biomater. 2022; 2022:6585305.

PMID: 36119660 PMC: 9473880. DOI: 10.1155/2022/6585305.


Imaging Constructs: The Rise of Iron Oxide Nanoparticles.

Cretu B, Dodi G, Shavandi A, Gardikiotis I, Serban I, Balan V Molecules. 2021; 26(11).

PMID: 34198906 PMC: 8201099. DOI: 10.3390/molecules26113437.


Magnetic Nanoparticles as MRI Contrast Agents.

Avasthi A, Caro C, Pozo-Torres E, Pernia Leal M, Garcia-Martin M Top Curr Chem (Cham). 2020; 378(3):40.

PMID: 32382832 PMC: 8203530. DOI: 10.1007/s41061-020-00302-w.


Progress in the Development of Chitosan-Based Biomaterials for Tissue Engineering and Regenerative Medicine.

Sultankulov B, Berillo D, Sultankulova K, Tokay T, Saparov A Biomolecules. 2019; 9(9).

PMID: 31509976 PMC: 6770583. DOI: 10.3390/biom9090470.


References
1.
Sun C, Lee J, Zhang M . Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 2008; 60(11):1252-1265. PMC: 2702670. DOI: 10.1016/j.addr.2008.03.018. View

2.
Xie J, Chen K, Lee H, Xu C, Hsu A, Peng S . Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. J Am Chem Soc. 2008; 130(24):7542-3. PMC: 2542944. DOI: 10.1021/ja802003h. View

3.
Lee C, Jeong H, Kim S, Kim E, Kim D, Lim S . SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes. Int J Pharm. 2009; 371(1-2):163-9. DOI: 10.1016/j.ijpharm.2008.12.021. View

4.
Park J, Kwon S, Lee M, Chung H, Kim J, Kim Y . Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials. 2005; 27(1):119-26. DOI: 10.1016/j.biomaterials.2005.05.028. View

5.
Rieder H, Meyer zum Buschenfelde K, Ramadori G . Functional spectrum of sinusoidal endothelial liver cells. Filtration, endocytosis, synthetic capacities and intercellular communication. J Hepatol. 1992; 15(1-2):237-50. DOI: 10.1016/0168-8278(92)90042-n. View